14-15 November 2022
Anna Bigas, Scientific Director of CIBERONC
Núria Malats, Training and Mobility Program Co-coordinator of CIBERONC
Ángel Carracedo, Scientific Committee Member and Translational Genomic Medicine Programme Coordinator of CIBERER
Chairs: Sonia Domínguez and Laura Sánchez
Ángel Carracedo. Personalised medicine: Challenges and hopes
Chairs: Luis Galán and Laura Sánchez
Manuel Torralba. Developing an iPSC based in vitro conditional model as a platform for the study of mendelian diseases
Carlos Ruiz-Arenas. Encoding gene expression into biological functions using deep learning
Chairs: Sara Crespo and Sonia Domínguez
Teresa Rodrigo. Head of the Animal Experimentation Unit at the University of Barcelona
Davide Cirillo. Head of the Machine Learning for Biomedical Research Unit at BSC
Meritxell Rovira. Principal Investigator, Regenerative Medicine Program at IDIBELL
Chairs: Sara Crespo and Rubén Giménez
Pedro Garrido. Exploring transcriptome diversity of human liver using nanopore sequencing
Belén de la Morena. Dissection of the largest cohort of structural variants and detection of new mechanisms involved in antithrombin deficiency by nanopore sequencing
Chairs: Sara Crespo and Rubén Giménez
Chairs: Rubén Giménez and Susana Torres
Chairs: Rubén Giménez and Susana Torres
Marta Lalinde. A new in vivo model to study the anti-tumorigenic effect of senolysis
Anna Maria Lucianò. Melanoma-specific bcl-xL induces proinflammatory macrophage polarization and recruitment through NFKB signaling pathway
Chairs: Marta Bort and Rubén Giménez
Sonia Guedán. CAR-T cells for cancer treatment
Chairs: Marta Bort and Sonia Domínguez
Heribert Playà. Chronic lymphocytic leukemia patient-derived xenograft as a model of clonal evolu- tion towards Richter transformation
Alberto Díaz. Characterization of UBTF-MAML3 as a new marker of metastatic PPGL: in search of a personalized treatment
Chairs: Marta Bort and Laura Sánchez
Ane Amundarain. Aptamers as delivery agents for RNA-based therapies against Multiple Myeloma
Ana Pilar Gómez. Selective protein degradation using camelid nanobodies as a potential therapeutic approach for rare dominant-retinal dystrophies
Chair: Luis Galán
Manolo Castellano. Alternative scientific careers: Opening the mind to contribute to society
Chairs: Luis Galán and Susana Torres
Manolo Castellano. Recruiter I+D+i and Headhunter
Alfredo Giménez. Associate Editor at Nature Metabolism
Irene Rius. Medical Science Liaison at Seagen
Jorge Barbazan. Associate Scientist at NASASBIOTECH SL. and Translational Oncology Researcher
Chairs: Sara Crespo and Susana Torres
Andrea Moreno. Assessment of CD5 and CD6 expression levels in PBMCs as potential biomarkers in advanced-stage NSCLC patients treated with immu- notherapy
Catarina Alexandra Da Silva. Immune biomarkers of survival in Multiple Myeloma patients treated with lenalidomide and dexamethasone
Gema Moreno Bueno. Training and Mobility Programme Coordinator of CIBERONC
Luis Pérez-Jurado. Training and Mobility Programme Coordinator of CIBERER
Poster instructions: the selected format for the poster party session will be DinA0 and vertically oriented.
Abstract list: you can download it clicking here